Toll Free: 1-888-928-9744
Published: May, 2015 | Pages:
50 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Cytokinetics, Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct's, 'Cytokinetics, Inc. - Product Pipeline Review - 2015', provides an overview of the Cytokinetics, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Cytokinetics, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Cytokinetics, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Cytokinetics, Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Cytokinetics, Inc.'s pipeline products Reason to Buy - Evaluate Cytokinetics, Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Cytokinetics, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Cytokinetics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Cytokinetics, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Cytokinetics, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope - Explore the dormant and discontinued projects of Cytokinetics, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 4 Cytokinetics, Inc. Snapshot 5 Cytokinetics, Inc. Overview 5 Key Information 5 Key Facts 5 Cytokinetics, Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 Cytokinetics, Inc. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Out-Licensed Products 10 Out-Licensed Products/Combination Treatment Modalities 11 Cytokinetics, Inc. - Pipeline Products Glance 12 Cytokinetics, Inc. - Clinical Stage Pipeline Products 12 Phase II Products/Combination Treatment Modalities 12 Phase I Products/Combination Treatment Modalities 13 Cytokinetics, Inc. - Early Stage Pipeline Products 14 Preclinical Products/Combination Treatment Modalities 14 Cytokinetics, Inc. - Drug Profiles 15 tirasemtiv 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 CK-2127107 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 CK-2018488 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 CK-2066260 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 Small Molecule to Inhibit Myosin for COPD, Asthma And Pulmonary Arterial Hypertension 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 Small Molecules for Cardiovascular Diseases 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 Cytokinetics, Inc. - Pipeline Analysis 27 Cytokinetics, Inc. - Pipeline Products by Target 27 Cytokinetics, Inc. - Pipeline Products by Route of Administration 28 Cytokinetics, Inc. - Pipeline Products by Molecule Type 29 Cytokinetics, Inc. - Pipeline Products by Mechanism of Action 30 Cytokinetics, Inc. - Recent Pipeline Updates 31 Cytokinetics, Inc. - Dormant Projects 39 Cytokinetics, Inc. - Company Statement 40 Cytokinetics, Inc. - Locations And Subsidiaries 48 Head Office 48 Appendix 49 Methodology 49 Coverage 49 Secondary Research 49 Primary Research 49 Expert Panel Validation 49 Contact Us 49 Disclaimer 50
List of Tables
Cytokinetics, Inc., Key Information 5 Cytokinetics, Inc., Key Facts 5 Cytokinetics, Inc. - Pipeline by Indication, 2015 7 Cytokinetics, Inc. - Pipeline by Stage of Development, 2015 8 Cytokinetics, Inc. - Monotherapy Products in Pipeline, 2015 9 Cytokinetics, Inc. - Out-Licensed Products in Pipeline, 2015 10 Cytokinetics, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2015 11 Cytokinetics, Inc. - Phase II, 2015 12 Cytokinetics, Inc. - Phase I, 2015 13 Cytokinetics, Inc. - Preclinical, 2015 14 Cytokinetics, Inc. - Pipeline by Target, 2015 27 Cytokinetics, Inc. - Pipeline by Route of Administration, 2015 28 Cytokinetics, Inc. - Pipeline by Molecule Type, 2015 29 Cytokinetics, Inc. - Pipeline Products by Mechanism of Action, 2015 30 Cytokinetics, Inc. - Recent Pipeline Updates, 2015 31 Cytokinetics, Inc. - Dormant Developmental Projects,2015 39
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.